Date: 31 October 2026
Board Meeting Outcomes
All seven special resolutions proposed in the postal ballot notice dated 01 October 2026 have been approved by shareholders with requisite majority. The voting period commenced on 02 October 2026 and concluded on 31 October 2026. The resolutions are deemed passed on 31 October 2026.
Approved resolutions include:
- Item 1: Approval of the Sun Pharma Employees Stock Option Plan 2026 ("ESOP 2026") and Provision of Funds to the Trust
- Item 2: Approval of Secondary Acquisition of Equity Shares by the Trust
- Item 3: Approval for Extension of ESOP 2026 to Eligible Employees of Subsidiary Companies
- Item 4: Approval for Enhancement of Limits under Section 186 of the Companies Act, 2013
- Item 5: Approval for Enhancement of borrowing limit under Section 180(1)(c) of the Companies Act, 2013
- Item 6: Approval for Creation of Security under Section 180(1)(a) of the Companies Act, 2013
- Item 7: Approval for Creation of Encumbrance over Shares Pursuant to Regulation 24(5) of the SEBI Listing Regulations
The voting results have been submitted to exchanges in XBRL mode as required under Regulation 44(3) of the SEBI Listing Regulations. The Scrutinizer's Report dated 31 October 2026 is available on the company's website at www.sunpharma.com.
Other Operational / Legal / Strategic Disclosures
The postal ballot process was conducted pursuant to the notice dated 01 October 2026. The Scrutinizer's Report confirms all resolutions passed with requisite majority.